Summary 17
Herpesviruses encode miRNAs that target both virus and host genes; however their role in herpesvirus 18 biology is poorly understood. We previously identified eight miRNAs encoded by OvHV-2; the 19 causative agent of malignant catarrhal fever (MCF) and have now investigated the role of these 20 miRNAs in regulating expression of OvHV-2 genes that play important roles in virus biology. ORF 21 20 (cell cycle inhibition), ORF 50 (reactivation) and ORF 73 (latency maintenance) each contain 22 predicted targets for several OvHV-2 miRNAs. Co-transfection of miRNA mimics with luciferase 23 reporter constructs containing the predicted targets showed the 5' UTRs of ORF 20 and ORF 73 24 contain functional targets for ovhv-miR-2 and ovhv2-miR-8 respectively, and the 3'UTR of ORF 50 25 contains a functional target for ovhv2-miR-5. Transfection of BJ1035 cells (an OvHV-2 infected 26 bovine T cell line) with the relevant miRNA mimic resulted in a significant decrease in ORF 50 and a 27 smaller but non-significant decrease in ORF 20. However, we were unable to demonstrate a decrease 28 in ORF 73. MCF is a disease of dysregulated lymphocyte proliferation, miRNA inhibition of ORF 20 29
Introduction 35
Malignant catarrhal fever (MCF) is a fatal disease of cattle and other ruminants caused by viruses in 36 the genus Macavirus of the subfamily Gammaherpesvirinae (Russell et al., 2009) . The disease occurs 37 as a result of infection of susceptible hosts by contact with an asymptomatic carrier species that acts 38 as a virus reservoir. Ovine herpesvirus-2 (OvHV-2) sub-clinically infects most sheep and is the major 39 cause of MCF worldwide (Russell et al., 2009) . In both sheep and cattle, OvHV-2 infects CD2 + T 40 lymphocytes (Meier-Trummer et al., 2010; Schock et al., 1998) but only in cattle does virus infection 41 cause dysregulation of lymphoid cell function leading to uncontrolled proliferation, cytotoxicity and 42 MCF disease. The proliferation of infected bovine T cells is dependent on the cytokine interleukin-2 43 (IL-2) and immortalized T cell lines can be cultured from affected cattle. The infected bovine T cells 44 do not support productive virus replication and have been described as large granular lymphocytes 45 (LGLs) (Reid et al., 1989) in part due to expression of perforin (Nelson et al., 2010) ; and unlike 46 sheep, infected cattle cannot transmit the virus to other susceptible hosts (Russell et al., 2009 ). The 47 mechanism by which OvHV-2 induces MCF in cattle is unknown; virus-induced cytopathology is 48 thought not to be involved in lesion development and it has been proposed that tissue damage arises 49 from non-antigen specific, MHC unrestricted cytotoxicity of the virus-infected LGLs (Cook & 50 Splitter, 1988) . 51
MicroRNAs (miRNAs) are short (21-23nt) RNAs that act as post-transcriptional inhibitors of gene 52 expression. Cellular miRNAs expressed in the nucleus are derived from primary transcripts (pri-53 miRNAs) that are processed by the enzyme Drosha to form a shorter precursor miRNA (pre-miRNA). 54
These pre-miRNAs are exported from the nucleus and once in the cytoplasm are further cleaved by 55 the enzyme Dicer to produce a transient double-stranded precursor; where one strand is designated the 56 miRNA or guide strand and the complementary strand is designated the miRNA* or passenger strand. 57
The miRNA is stably incorporated into the RNA-induced silencing complex and guides it to the target 58 mRNA, which represses translation by a number of mechanisms including mRNA degradation and 59 inhibition of translation. The interaction of miRNAs with target mRNAs is mediated by a seed region, 60 nucleotides 2-7 or 2-8 at the 5'end of the miRNA (Bartel, 2009 )Most miRNA targets identified to date 61 are present in the 3'UTR of mRNAs, however some miRNAs have been reported that functionally 62 target the 5'UTR (Grey et al., 2010; Tay et al., 2009) . 63
To date, over 250 virus-encoded miRNAs have been identified, the majority from herpesviruses 64 (Grundhoff & Sullivan, 2011) . Herpesvirus-encoded miRNAs have been shown to regulate both 65 cellular and viral gene expression and to influence cell processes including proliferation. In Marek's 66 disease virus (MDV), the deletion of a single virus-encoded miRNA abrogates virus-induced cellular 67 transformation (Zhao et al., 2011) and in Epstein Barr virus (EBV) a cluster of miRNAs has been 68 implicated in controlling virus-induced B cell proliferation and transformation (Feederle et al., 2011a; Feederle et al., 2011b; Seto et al., 2010) . We have previously demonstrated that OvHV-2 encodes at 70 least eight miRNAs (Levy et al., 2012) expressed within the immortalized bovine LGL line, BJ1035; 71 and hypothesize that these play a critical role in MCF pathogenesis. In order to investigate the role of 72 virus-encoded miRNAs in OvHV-2 pathogenesis it is necessary to identify their viral and cellular 73 targets. In this study we investigated the role of OvHV-2 encoded miRNAs in regulating selected 74 virus gene expression. There is no in vitro infection system for studying OvHV-2; the only cells in 75 which virus gene expression can be studied are immortalized LGL lines like BJ1035 (Levy et al., 76 2012 . All cells in these LGL lines are virus genome positive and in the majority OvHV-2 is latent; 77 however, some lytic cycle gene expression occurs in a small proportion of the cells (Rosbottom et al., 78 2002; Thonur et al., 2006) . 79
Results 80
Prediction of OvHV-2 encoded miRNA targets in the OvHV-2 genome. 81
Potential miRNA targets within the OvHV-2 genome were initially identified by scanning the entire 82
OvHV-2 genome using BLASTN (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to align the sequences 83 complementary to the ovhv2-miRs in the OvHV-2 genome (GenBank, AY839756) (Hart et al., 2007) . 84
Targets were then mapped to the 5'UTR or 3'UTR of OvHV2 genes. Only a small number of OvHV-85 2 mRNAs have been mapped previously therefore for the majority of genes the 5´UTRs were 86 considered to span the region from the start codon to the predicted TATA box. For 3'UTRs the region 87 from the stop codon to the predicted polyadenylation site was used. This analysis identified potential 88 targets in 33 OvHV-2 genes, representing all classes of virus gene; immediate early, early and late, 89
and both structural and non-structural proteins. 90
For validation of predicted targets we focussed on genes/proteins predicted to play important roles in 91 virus biology and pathogenesis. We chose to analyse targets present in the 5' or 3'UTR of three virus 92 genes, ORF 20, ORF 50 and ORF 73. ORF 20 has been shown to induce cell cycle arrest in other 93
herpesviruses (Nascimento et al., 2009 ), and the other two genes encode proteins that play contrary 94 roles in virus latency. ORF 50 is crucial for virus reactivation from latency and ORF 73 is important 95 for the maintenance of latency (Ackermann, 2006) . The positions of the predicted miRNA target sites 96 in ORF 20, ORF 50 and ORF 73 are detailed in Table 1 . 97 miRNAs function by targeting expressed mRNAs, ORF 20 and 50 are only predicted open 98 reading frames from the genomic sequence; and the ORF 73 transcript is only partially mapped 99
The annotated OvHV-2 genome predicts that ORF 20 overlaps with both ORF 19 and ORF 21 ( Fig.  102 1A). To allow detection of ORF 20 only, cDNA synthesis was primed using a gene-specific primer 103 located 406 bp upstream (42530-41549) of the ORF 19 TATA box (41106). This primer will not 104 prime ORF 21 mRNA as it is the same sense as the ORF 21 transcript. Fig. 1B shows the 118 bp 105 amplicon, the sequence of which was 100% identical to the predicted ORF 20 sequence (39294 -106 41641) and includes the target sequence (41617 -41635) for ovhv-2-miR-2 ( Fig. 1B) . 107
The ORF 50 and Ov6 transcripts are transcribed in the same direction, with the Ov6 TATA box lying 108 94 bp downstream of the ORF 50 poly A site. ORF 50 is spliced and ORF 49 lies within the ORF 50 109 intronic sequence transcribed in the opposite direction ( Fig. 1A ). We were unable to prime cDNA 110 synthesis efficiently using an ORF 50 gene specific primer due to the limited number of nucleotides 111 between the predicted target sequence and the poly A site, we therefore used both oligo dT and 112 random primers to prime cDNA synthesis. PCR primers (78080-78099 and 79205-79181) were 113 designed to generate an 1101bp amplicon, from the middle of the second exon of ORF 50 to the poly 114 ORF 73 lies downstream of the ORF 75 transcript and is transcribed in the same direction ( Fig. 1A) . 120
The annotated OvHV-2 genome (GenBank, AY839756) (Hart et al., 2007) states the 5' terminus of 121 the ORF 73 transcript at nt 121049, 31 bp upstream of the predicted poly A site for ORF 75. We used 122 both oligo dT and random primers to prime cDNA synthesis. PCR primers (120514-120534 and 123 121060-121041) generates a 536 bp amplicon from within the coding sequence of ORF 73 to the 124 predicted end of ORF 73 mRNA. Fig. 1D shows this 536 bp amplicon, the sequence of which was 125 100% identical to the predicted ORF 73 and includes the target sequence (120817-120839) for ovhv-126 2-miR-8. 127
Inhibition of gene expression 128
BJ1035 is a mixed population of cells with respect to virus life cycle; the majority are latently infected 129 but a small proportion express early and late virus genes (Rosbottom et al., 2002; Thonur et al., 130 2006) . OvHV-2 miRNAs may be also differentially expressed in the proportion of cells in culture in 131 which the virus is latent compared to those cells where the virus is reactivating making analysis of 132 inhibition of gene expression following introduction of exogenous miRNAs complex. We therefore 133 initially assessed the ability of the ovhv2-miRNAs to interact with their predicted targets using a 134 luciferase expression assay. 135
We have previously shown that insertion of a predicted 5'UTR downstream of an exogenous 136 promoter, e.g CMV IE, can result in the expression of transcripts in which the start site does not 137 reflect that of the native transcript (Grey et al., 2010) . In keeping with our previous studies, when 138 analysing targets in 5'UTRs we cloned a region approximately 1000bp upstream of the AUG in an 139 attempt to allow correct expression from the natural promoter. For all experiments a luciferase 140 expressing vector lacking OvHV-2 sequnces was used to investigate off-target effects: no significant 141 reduction in luciferase expression was seen using any of the ovhv-2-miRs. 142
The 5'UTR of ORF 20 contained a predicted target site for ovhv2-miR-2, (Table 1; Fig. 3 ). BHK-21 143 cells were co-transfected with reporter constructs and miRNA mimics as described and luciferase 144 expression levels were measured. The combination of the ORF 20 5'UTR reporter and ovhv2-miR-2 145 resulted in a 57.5 (± 10) % reduction (p ≤ 0.03) in luciferase expression using 100 nM mimics ( Fig.  146 2a) compared to control miRNA. The same degree of inhibition was observed using 50nM mimics 147 (data not shown). Ovhv2-miR-2 inhibited luciferase expression by 47.5(±15) % (p ≤ 0.003) even after 148 the mutation of the predicted target site in the 5'UTR ( Fig. 2A ), suggesting that inhibition was not due 149 to interaction of ovhv2-miR-2 with the predicted target sequence. The 3'UTR of ORF 50 was 150 predicted to contain a target site for ovhv2-miR-5 (Table 1, The 5'UTR of ORF 73 was predicted to contain two separate sites for ovhv2-miR-8 (Table 1, Fig. 3 ). 155
The combination of 5'UTR of ORF 73 and ovhv2-miR-8 mimic resulted in a 45(± 8) % decrease (p ≤ 156 0.001) in luciferase expression ( Fig 2C) . Mutation of either of the predicted ovhv2-miR-8 target sites 157 abolished the inhibitory effect of ovhv2-miR-8. 158
To further investigate inhibition of the expression of these OvHV-2 genes by the ovhv2-miRs we 159 developed RT-qPCR assays for ORF 20, 50 and 73 transcripts. BJ1035 cells were transfected with the 160 relevant ovhv2-miR mimics or control miRNA for 24 or 48h at which point cells were harvested, 161
RNA isolated and qPCR carried out. We were able to demonstrate a 42(±15) % reduction in levels of 162 ORF 50 transcript following transfection with ovhv2-miR-5 ( Fig. 4a, P=0.042) . Although there 163 appeared to be a 12.8 (±13) % reduction in levels of ORF 20 transcript following transfection with 164 ovhv2-miR-2 ( Fig. 4b ), this was not significant (P=0.532). Furthermore, we were unable to 165 demonstrate any reduction in levels of ORF 73 transcript following transfection with ovhv2-miR-8 (+ 166 7.3(±13.9) %) ( Fig. 4c, P=0.532) . 167
Discussion
OvHV-2 induced malignant catarrhal fever in susceptible hosts is a disease of dysregulated 169 lymphocyte proliferation and cell function. However, these susceptible hosts cannot transmit the 170 virus. In contrast, infection of carrier hosts is asymptomatic, but these are infectious. A previous study 171 has shown that this virus expresses at least eight miRNAs (Levy et al., 2012) . In this study we 172 investigated the control of expression of three virus genes important for control of cell cycle (ORF 20) 173 and virus latency (ORF 50 and ORF 73) by virus-encoded miRNAs. 174
The 3' UTR of ORF 50 was predicted to be targeted by ovhv2-miR-5. This interaction was confirmed 175 by both the luciferase assay and by inhibition of ORF 50 miRNA levels in BJ1035 cells transfected 176 with ovhv2-miR-5. Thus we have demonstrated that expression of ORF 50, whose main role is to 177 drive reactivation from latency, can be inhibited by a viral encoded miRNA. 178
The 5'UTR of ORF 20 was predicted to contain one site recognised by ovhv2-miR-2. Ovhv2-miR-2 179 did inhibit luciferase expression; however mutation of the predicted site did not abolish this inhibition. 180
Thus, whilst we have demonstrated that ovhv2-miR-2 inhibits expression of a transcript containing 181 the 5'UTR of ORF 20, we cannot definitively show that this inhibition is a consequence of its 182 interaction with the target site predicted in the original analysis. We also investigated the ability of 183 ovhv2-miR-2 to inhibit ORF 20 expression in BJ1035 cells. We were able to demonstrate a small 184 reduction in ORF 20 mRNA levels in BJ1035 cells transfected with this ovhv2-miR-2; however was 185 not statistically significant. 186 ORF 73 was predicted to contain two sites recognised by the ovhv2-miR-8 seed sequence located nine 187 bases apart (Fig. 3) . ovhv2-miR-8 was able to inhibit gene expression in the luciferase assay and 188 mutation of either of these sites resulted in loss of inhibition. Further analysis of the binding of ovhv2-189 miR-8 to this region using RNAhybrid showed that site 1 was predicted to bind the miRNA with high 190 efficiency, but RNAhybrid did not identify site 2. Site 2 lies in the region that is likely to interact with 191 the 3' end of a miRNA interacting at site 1. It is therefore likely that site 1 is functional and that the 192 loss of inhibition seen when site two is mutated is due to loss of non-seed sequence interactions. We 193 were unable to demonstrate any reduction in ORF 73 mRNA levels following transfection of ovhv2-194 miR-8 into BJ1035 cells. 195
The inability to demonstrate inhibition of ORF 20 and ORF 73 expression in BJ1035 cells may be due 196 to a number of factors e.g. the inherent variability within BJ1035 cells could result in variation in 197 baseline levels of virus gene expression or the ovhv2-miRs may inhibit translation ( the luciferase 198 assay measured protein levels) of ORFs 20 and 73 without significantly affecting mRNA levels. ORF 199 73 is the main latency associated protein and so will be expressed in the majority of BJ1035 cells. Our 200 transfection efficiency for BJ1035s is approximately 40-45% (data not shown) it is possible that the 201 level of inhibition obtained is not sufficient to be seen under these experimental conditions. 202
In all three classes of herpesvirus, homologues of ORF 20 (the UL24 family) have been shown to 203 induce cell cycle arrest and inactivate the cyclin B/cdc2 complex (Nascimento et al., 2009) . The 204 conservation of the structure and function of these proteins during herpesvirus evolution strongly 205 suggests that they are important in herpesvirus biology (Nascimento et al., 2009 suggested that these miRNAs play a role in control of EBV latency. The OvHV-2 immortalized LGL 233 cell line, BJ1035 is a mixed population of cells with respect to virus life cycle; the majority are 234 latently infected but a small proportion express early and late virus genes (Rosbottom et al., 2002; 235 Thonur et al., 2006) . Thus, OvHV-2 miRNAs may be differentially expressed in the proportion of 236 cells in culture in which the virus is latent compared to those cells where the virus is reactivating. 237
The proteins encoded by ORF 50 and ORF 73 play important, but contrary roles in relation to latency; 238 ORF 50 is critical for virus reactivation and ORF 73 is important in maintenance of viral latency 239 (Ackermann, 2006) . Bellare and Ganem (Bellare & Ganem, 2009) proposed that miRNA-induced 240 inhibition of virus genes is not the sole regulator of reactivation/latency but rather that they ensure 241 that fluctuations in virus mRNA levels do not result in reactivation in conditions that are unfavourable 242 for viral replication, i.e. the miRNAs act as a type of rheostat to control the levels of virus gene 243 expression. The apparent contradiction of having miRNAs that act to both inhibit and encourage 244 reactivation expressed in the same cell line can be explained by considering the mixed nature of the 245
BJ1035 line. The differential expression of individual virus miRNAs in individual cells could respond 246
to changes in the cellular environment acting to regulate virus gene expression . The factors which 247 determine the maintenance of, or reactivation from, latency, are complex, by demonstrating miRNA 248 mediated control of both "pro and anti-reactivation genes" our data adds support to the hypothesis 249 that miRNAs represent an additional layer of control exerted by the virus to control the latent state. 250
251
Methods 252
Target identification. Potential miRNA targets within the OvHV-2 genome were identified using 253 BLASTN (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to align the sequences complementary to the 254 ovhv2-miRs in the OvHV-2 genome (GenBank, AY839756) (Hart et al., 2007) . Targets were mapped 255 to the 5'UTR or 3'UTR of OvHV2 genes. Only a small number of OvHV-2 mRNAs have been 256 mapped previously therefore, for the majority of genes, the 5´UTRs were considered to span the 257 region from the start codon to the predicted TATA box. For 3'UTRs the region from the stop codon to 258 the predicted polyadenylation site was used. Sites chosen for validation were also analysed by 259
RNAhybrid (Rehmsmeier et al., 2004) Pharmaceutical) and cultured at 37 o C with 5% CO 2 . 267
Cloning of target sites. Sequences spanning the 3' and 5' UTRs of the selected genes were amplified 268 by PCR ( Fig S1) . For 3'UTRs the region from the stop codon to the predicted poly A site was 269 amplified, for analysis of 5'UTRs approximately 1000 bp upstream of the ATG was amplified, 3´UTRs were cloned into the psiCHECK TM -2 Vector (Promega) downstream of a renilla luciferase 271 reporter gene (Rluc) and 5´UTRs into the pGL4.10 vector (Promega) upstream of a firefly luciferase 272 reporter gene (Fluc). Operon, Germany) were designed such that each primer was 42-45 nt in length, with a Tm of >78 o C. 290 (Table S1 ). All mutations were confirmed by sequencing. 291 cDNA synthesis. RNA was isolated from BJ1035 cells using an RNeasy kit (Qiagen). 1 μg RNA was 292 digested with RQ1 DNase (Promega) for 30 min at 37 ˚C. For analysis of ORF 20, cDNA was primed 293 with 250 ng or 66 ng of specific primer (41530 -CTGAAACATGGCCTCCAACT -41549) .For 294 analysis of ORF 50, cDNA was primed using 250 ng oligo dT primer or random primers (Promega; 295 equivalent to 0.5 g.g -1 RNA). cDNA was synthesized using AMV reverse transcriptase for 1 hr at 296 42 ˚C (oligo dT and specific primer) or 37 ˚C (random primer). Following an initial denaturation of 5 min at 95 ˚C, 40 cycles (30 s at 95 ˚C, 30 s at 58 ˚C and 1 min 305 15 s at 72 ˚C) were performed prior to a final extension of 5 min at 72 ˚C. 100 ng of BJ1035 DNA 306 was used as a positive control for the PCR. Samples were run on a 2% agarose gel and visualized, 307 extracted, cloned into pCR2.1-Topo (Invitrogen) and sequenced. 308 RT-qPCR. RNA was isolated using an RNeasy kit (Qiagen). 1 g of RNA was digested with RQ1 309 Dnase (Promega) for 30 min at 37 ˚C. cDNA was primed using 250ng Oligo dT primer (Promega; 310 equivalent to 0.5 g/g RNA) and synthesized using AMV reverse transcriptase for 1 hr at 42 ˚C. μl. Transcript levels were normalised to GAPDH and the relative expression was calculated using 2 -319
ΔΔCt (Livak & Schmittgen, 2001) . Three technical replicates were performed for each biological 320
replicate. Data were plotted as fold change in relation to negative control. 321
Statistics. For Luciferase assays groups were compared using single factor analysis of variance 322 (ANOVA) test followed by Tukey's post-hoc test. P values represent results from the post-hoc test. 323
To compare levels of ORF 20, ORF 50 or ORF 73 transcripts after transfection ovhv2-mirs standard 324 linear mixed effect (LME) statistical models were used. Technical replicates were entered as random 325 effects to account for the repeated sampling of the same cell line. Whether the data was test or control 326 was entered as the fixed effect. For ORF 50 and ORF 73 three independent runs were performed, and 327 this run parameter was entered as a potential confounding fixed effect prior to control/test status. 328
Examination of residuals demonstrated a normal distribution. The LME were carried out in R (version Nucleotide numbers are from (GenBank, AY839756) (Hart et al., 2007) . 
